John Vissing

John Vissing

Clinical Professor

Member of:

  • Neurology


Publication year:
All
26 - 30 out of 30Page size: 25
Sort by: 1st author
  1. Published

    Reply: Dominant LGMD2A: Alternative diagnosis or hidden digenism?

    Vissing, John & Duno, M., 2017, In: Brain. 140, 2, 2 p., e8.

    Research output: Contribution to journal › Comment/debate › Research

  2. Published

    PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose

    Voermans, N. C., Preisler, N., Madsen, K. L., Janssen, M. C. H., Kusters, B., Abu Bakar, N., Conte, F., Lamberti, V. M. L., Nusman, F., van Engelen, B. G., van Scherpenzeel, M., Vissing, John & Lefeber, D. J., 2017, In: Neuromuscular Disorders. 27, 4, p. 370-376

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark

    Witting, N., Werlauff, U., Duno, M. & Vissing, John, Apr 2017, In: Neurology: Genetics. 3, 2, 15 p., e140.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience

    van der Ploeg, A. T., Kruijshaar, M. E., Toscano, A., Laforêt, P., Angelini, C., Lachmann, R. H., Pascual Pascual, S. I., Roberts, M., Rösler, K., Stulnig, T. M., van Doorn, P. A., Van den Bergh, P. Y. K., Vissing, John, Schoser, B. & European Pompe Consortium, E. P. C., Jun 2017, In: European Journal of Neurology. 24, 6, p. 768-e31

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Treatment Opportunities in Patients With Metabolic Myopathies

    Ørngreen, M. C. & Vissing, John, 2017, In: Current Treatment Options in Neurology. 19, 11, 16 p., 37.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 Next

ID: 915367